John Kalafut, Ph.D., Director of Informatics Research and Strategy, MEDRAD Corporate Development and Innovations, answers your questions on achieving optimal CT opacification.
Read More

AngioJet Thrombectomy is associated with a reduction in Late Stent Thrombosis and MACE in STEMI patients with large thrombus burden.
Read More

A University of Pittsburgh Medical Center (UPMC) clinical trial has resulted in a higher percentage of diagnostic quality exams to exclude pulmonary embolism when MEDRAD P3T for Stellant CT Injection System is employed.
Read More

Two separate articles about Contrast Induced Nephropathy show higher risk of death and the importance in prevention of using the smallest dose of contrast needed.
Read More

Research has shown that MEDRAD's P3T™ Cardiac software has resulted in a higher percentage of PE exams ranked as diagnostic without limitation*.
Read More

Awareness of deep vein thrombosis (DVT) risk factors and symptoms can significantly reduce adverse events associated with this serious but under-diagnosed condition.
Read More

A hospital facility should be concerned with medical professional liability of extravasations. The potential liability of a moderate and severe extravasation are $14,118 and $94,056, respectively.
Read More

XDS technology enables quick and highly accurate detection of extravasated fluid at less than 20mL, but typically between 5mL and 11mL.
Read More

Despite the risk of errors and inconsistencies in manual documentation, most radiology departments lack the tools to automate documentation of contrast media administered intravenously.
Read More

UPMC research demonstrates that P3T Cardiac is proven to deliver a higher percentage of PE exams ranked “diagnostic without limitation” when compared to standard protocol.*³
Read More

High Prostate Specific Antigen (PSA) levels and repeat negative biopsy remains a problem for diagnosing prostate cancer.
Read More

Optimizing the treatment options for the patient is the positive result of making the distinction between intra-capsular and extra-capsular prostate cancer.
Read More

In a JCAT study, Tom Lombardi, M.D. found the research showed high sensitivity while maintaining high specificity in the subcutaneous detection of contrast extravasation using radiofrequency (RF) permittivity sensitivity.
Read More

Newly completed research now quantifies reduced set-up and infusion time in automated FDG infusion for Positron Emission Tomography (PET) imaging procedures.
Read More

Are you trying to increase effiency in your MR suite? It is a common request in MRI these days. A couple ways of achieving it are to reduce scan interruptions and turnaround patients more quickly.
Read More

PET technologists are exposed to radiation during the manual preparation and handling of FDG for PET imaging. Validation tests confirm that MEDRAD's Intego™ PET Infusion System reduces the radiation dose from preparation and handling by more than 20%.
Read More

Although serious extravasations are rare, a single major event can put your patient at risk, subject your hospital and staff to liability costs, and potentially damage your hospital’s reputation.
Read More

Travellers have nearly triple the normal risk of developing a venous thromboembolism, a dangerous blood clot, researchers from Havard University reported in July 2009.
Read More